These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21235326)

  • 1. NANOG has a role in mesenchymal stem cells' immunomodulatory effect.
    Sun Z; Han Q; Zhu Y; Li Z; Chen B; Liao L; Bian C; Li J; Shao C; Zhao RC
    Stem Cells Dev; 2011 Sep; 20(9):1521-8. PubMed ID: 21235326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1.
    Zhu Y; Sun Z; Han Q; Liao L; Wang J; Bian C; Li J; Yan X; Liu Y; Shao C; Zhao RC
    Leukemia; 2009 May; 23(5):925-33. PubMed ID: 19148141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2.
    Pierantozzi E; Gava B; Manini I; Roviello F; Marotta G; Chiavarelli M; Sorrentino V
    Stem Cells Dev; 2011 May; 20(5):915-23. PubMed ID: 20879854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1 Transduced Mesenchymal Stem Cells Have Profound Modulatory Effects on DCs and T Cells.
    Daneshmandi S; Karimi MH; Pourfathollah AA
    Iran J Immunol; 2017 Mar; 14(1):13-23. PubMed ID: 28341815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
    Cipriani P; Di Benedetto P; Liakouli V; Del Papa B; Di Padova M; Di Ianni M; Marrelli A; Alesse E; Giacomelli R
    Clin Exp Immunol; 2013 Aug; 173(2):195-206. PubMed ID: 23607751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
    Zimmermann JA; McDevitt TC
    Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.
    Tomic S; Djokic J; Vasilijic S; Vucevic D; Todorovic V; Supic G; Colic M
    Stem Cells Dev; 2011 Apr; 20(4):695-708. PubMed ID: 20731536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate.
    Koh SH; Baik W; Noh MY; Cho GW; Kim HY; Kim KS; Kim SH
    Exp Neurol; 2012 Jan; 233(1):472-80. PubMed ID: 22119626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident Cardiac Atrial appendage Stem Cells.
    Windmolders S; De Boeck A; Koninckx R; Daniëls A; De Wever O; Bracke M; Hendrikx M; Hensen K; Rummens JL
    J Mol Cell Cardiol; 2014 Jan; 66():177-88. PubMed ID: 24326234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.
    Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Weimar W; Hoogduijn MJ
    Stem Cells Dev; 2010 Dec; 19(12):1843-53. PubMed ID: 20367242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB.
    Dorronsoro A; Ferrin I; Salcedo JM; Jakobsson E; Fernández-Rueda J; Lang V; Sepulveda P; Fechter K; Pennington D; Trigueros C
    Eur J Immunol; 2014 Feb; 44(2):480-8. PubMed ID: 24307058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Check-control of inflammation displayed by bone marrow mesenchymal stem cells in rheumatoid arthritis patients.
    Lamas JR; Mucientes A; Lajas C; Fernández-Gutiérrez B; Lópiz Y; Marco F; Jover JA; Abásolo L; Rodriguez-Rodriguez L
    Immunotherapy; 2019 Sep; 11(13):1107-1116. PubMed ID: 31378114
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytoplasmic NANOG-positive stromal cells promote human cervical cancer progression.
    Gu TT; Liu SY; Zheng PS
    Am J Pathol; 2012 Aug; 181(2):652-61. PubMed ID: 22683467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin.
    Liu R; Wang Y; Zhao X; Yang Y; Zhang K
    Eur J Dermatol; 2014; 24(5):560-7. PubMed ID: 25445090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism.
    Yan Z; Zhuansun Y; Chen R; Li J; Ran P
    Exp Cell Res; 2014 May; 324(1):65-74. PubMed ID: 24681107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of protein malnutrition on biological and immunomodulatory aspects of bone marrow mesenchymal stem cells.
    Dos Santos GG; Batool S; Hastreiter A; Sartori T; Nogueira-Pedro A; Borelli P; Fock RA
    Clin Nutr; 2017 Aug; 36(4):1149-1157. PubMed ID: 27623433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of the embryonic markers nanog, OCT-4, SSEA-1, SSEA-4, and frizzled-9 receptor in human periodontal ligament mesenchymal stem cells.
    Trubiani O; Zalzal SF; Paganelli R; Marchisio M; Giancola R; Pizzicannella J; Bühring HJ; Piattelli M; Caputi S; Nanci A
    J Cell Physiol; 2010 Oct; 225(1):123-31. PubMed ID: 20458727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanog promotes osteogenic differentiation of the mouse mesenchymal cell line C3H10T1/2 by modulating bone morphogenetic protein (BMP) signaling.
    Ogasawara T; Ohba S; Yano F; Kawaguchi H; Chung UI; Saito T; Yonehara Y; Nakatsuka T; Mori Y; Takato T; Hoshi K
    J Cell Physiol; 2013 Jan; 228(1):163-71. PubMed ID: 22585661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency.
    Ball SG; Shuttleworth A; Kielty CM
    Stem Cells; 2012 Mar; 30(3):548-60. PubMed ID: 22213560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.